Table 3. Tuberculosis trends from 2000 to 2017 by according to age group and gender.
| All | Pulmonary | Extra pulmonary | Lymh node | Other localizations | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Slope (SE) | r | Slope (SE) | r | Slope (SE) | r | Slope (SE) | r | Slope (SE) | r | |
| Over all | 0.58** (0.05) | 0.33 | -0.82**(0.04) | -0.67 | 1.37**(0.48) | 0.78 | 1.31** (0.106) | 0.63 | 0.28 (0.08) | 0.26 |
| Age groups (Years) | ||||||||||
| 0–19a | 0.30**(0.03) | 0.58 | -0.04 (0.042) | -0.16 | 0.38**(0.04) | 0.69 | 0.39**(0.09) | 0.49 | 0.26*(0.10) | 0.57 |
| 20–39 b | 0.075 (0.04) | 0.08 | -0.37** (0.042) | -0.53 | 0.28** (0.03) | 0.50 | 0.85**(0.06) | 0.80 | -0.26**(0.06) | -0.51 |
| 40–59 c | 0.11 (0.06) | 0.10 | -0.42** (0.066) | -0.46 | 0.39** (0.06) | 0.44 | 0.15 (0.10) | 0.20 | 0.014(0.06) | -0.03 |
| ≥60 c | -0.007 (0.028) | -0.02 | -0.20** (0.032) | -0.53 | 0.22**(0.02) | 0.69 | 0.25*(0.10) | 0.49 | 0.36**(0.07) | 0.62 |
| Gender | ||||||||||
| Men | -0.50** (0.05) | -0.35 | -0.83** (0.048) | -0.67 | 0.25**(0.05) | 0.30 | 0.194* (0.07) | 0.27 | -0.21*(0.08) | -0.32 |
| Women | 1.09**(0.02) | 0.90 | -0.014 | -0.026 | 1.14**(0.03) | 0.88 | 1.02**(0.09) | 0.66 | 0.46**(0.05) | 0.63 |
* p<0.05
** p<0.00001
a: corresponding to the vaccinated cohort
b: corresponding to the transient cohort that is getting vaccinated over years
c: corresponding to the not vaccinated cohort